Keyphrases
Kinase Inhibition
100%
Therapeutic Action
100%
Adult T-cell Leukemia
100%
PAK2
100%
PAK1
42%
Tumor-stroma Interaction
28%
PAK1 Inhibitor
28%
Cell Adhesion Molecule 1 (CADM1)
28%
North America
14%
Cell Proliferation
14%
Small Interfering RNA (siRNA)
14%
Targeted Therapy
14%
Cell Survival
14%
Gene Silencing
14%
Family Members
14%
Cell Adhesion
14%
Kinase Activity
14%
Frequency Effect
14%
Knockdown
14%
Patient Cohort
14%
Long-term Culture
14%
Prognostic Impact
14%
In Vivo Activity
14%
Systemic Dissemination
14%
In Vivo Xenograft Model
14%
PF-3758309
14%
Medicine and Dentistry
Phosphotransferase
100%
Adult T-Cell Leukemia/Lymphoma
100%
In Vitro
50%
Cell Survival
50%
Targeted Therapy
50%
Xenograft
50%
Cell Proliferation
50%
Small Interfering RNA
50%
Gene Inactivation
50%
Cell Line
50%
Cell Adhesion
50%
Diseases
50%
Biochemistry, Genetics and Molecular Biology
PAK2
100%
T Cell
100%
Phosphotransferase
100%
Kinase
100%
PAK1
42%
Isoform
28%
Genetics
14%
Cell Adhesion
14%
Small Interfering RNA
14%
Cell Survival
14%
Cell Proliferation
14%
Gene Inactivation
14%
Pharmacology, Toxicology and Pharmaceutical Science
Phosphotransferase
100%
T Cell Leukemia
100%
Small Interfering RNA
50%
Diseases
50%